Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial

Overview of attention for article published in Metabolic Brain Disease, February 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 47,953 followers.

RT @DanielJDrucker: Sitagliptin use in GDM. The informed consent form would be an interesting read https://t.co/1ixL4ISAac https://t.co/C7Z…

Reply Repost Favourite

RT @DanielJDrucker: Sitagliptin use in GDM. The informed consent form would be an interesting read https://t.co/1ixL4ISAac https://t.co/C7Z…

Reply Repost Favourite

Sitagliptin use in GDM. The informed consent form would be an interesting read https://t.co/QKDQP6q7uj… https://t.co/7KOrHaNYWj https://t.co/5rdKBHKQlC

Reply Repost Favourite

RT @DanielJDrucker: Sitagliptin use in GDM. The informed consent form would be an interesting read https://t.co/1ixL4ISAac https://t.co/C7Z…

Reply Repost Favourite

Sitagliptin use in GDM. The informed consent form would be an interesting read https://t.co/1ixL4ISAac https://t.co/C7ZRovAL6a

Reply Repost Favourite